Skip to Content

Clinical Trials Reporting

Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials

Public concern is high regarding the timely and complete reporting of clinical trial results, primarily when the trials are sponsored by the drug, biologicals, or device industries. Because academic researchers and their institutions often play a prominent role in such trials, these concerns challenge the integrity of the academic medical research community as well as the sponsors of the trials.

The AAMC held a small invitational conference in June 2005 to address these concerns. The conference produced this report, which contains principles and standards that should guide institutions and their investigators in the analysis and reporting of clinical trials in which they participate.


More on Research Principles

Principles for Protecting Integrity in the Conduct and Reporting of Clinical Trials


Principles for Strengthening the Integrity of Clinical Research External Link

Check out the Principles, from the April 2006 issue of the Public Library of Science journal PLoS Clinical Trials



Learn about AAMC medical research initiatives and publications.